Saturn V Capital Management Lp Top Holdings and 13F Report (2026) About Saturn V Capital Management LpInvestment ActivitySaturn V Capital Management Lp has $552.22 million in total holdings as of March 31, 2026.Saturn V Capital Management Lp owns shares of 21 different stocks, but just 11 companies or ETFs make up 80% of its holdings.Approximately 9.95% of the portfolio was purchased this quarter.About 17.80% of the portfolio was sold this quarter.This quarter, Saturn V Capital Management Lp has purchased 20 new stocks and bought additional shares in 10 stocks.Saturn V Capital Management Lp sold shares of 6 stocks and completely divested from 3 stocks this quarter.Largest Holdings ALUMIS INC $70,541,712Amylyx Pharmaceuticals $60,463,402ABIVAX SA $60,429,200Vaxcyte $47,913,555Pharvaris $33,939,606 Largest New Holdings this Quarter 137404109 - Candel Therapeutics $14,193,281 HoldingG9TY5A101 - Zura Bio $4,402,762 Holding02157Q109 - ALTO NEUROSCIENCE INC $2,000,698 Holding80401L803 - SATELLOS BIOSCIENCE INC $1,970,500 Holding Largest Purchases this Quarter Candel Therapeutics 2,896,588 shares (about $14.19M)Disc Medicine 151,497 shares (about $9.69M)Immix Biopharma 694,416 shares (about $6.33M)Zura Bio 739,960 shares (about $4.40M)Invivyd 3,213,698 shares (about $4.18M) Largest Sales this Quarter Cogent Biosciences 590,429 shares (about $22.73M)Jazz Pharmaceuticals 85,109 shares (about $16.09M)DYNE THERAPEUTICS INC 822,007 shares (about $14.90M)ABIVAX SA 106,483 shares (about $11.86M)Celcuity 35,191 shares (about $4.02M) Sector Allocation Over TimeMap of 500 Largest Holdings ofSaturn V Capital Management Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorALUMIS INC$70,541,712$1,456,668 â–²2.1%3,202,07512.8%COMAMLXAmylyx Pharmaceuticals$60,463,402$2,037,768 â–¼-3.3%4,349,88510.9%MedicalABIVAX SA$60,429,200$11,856,882 â–¼-16.4%542,69610.9%SPONSORED ADSPCVXVaxcyte$47,913,555$1,487,151 â–²3.2%824,5328.7%MedicalPHVSPharvaris$33,939,606$1,733,674 â–²5.4%1,201,4026.1%MedicalIMMXImmix Biopharma$33,648,559$6,326,130 â–²23.2%3,693,5856.1%MedicalCELCCelcuity$32,176,523$4,016,701 â–¼-11.1%281,9045.8%MedicalJAZZJazz Pharmaceuticals$30,807,777$16,089,856 â–¼-34.3%162,9615.6%MedicalIRONDisc Medicine$28,768,268$9,686,718 â–²50.8%449,9265.2%MedicalX4 PHARMACEUTICALS INC$26,665,948$2,709,759 â–²11.3%6,456,6464.8%COM NEWCOGTCogent Biosciences$24,119,181$22,725,612 â–¼-48.5%626,6354.4%MedicalMONOPAR THERAPEUTICS INC$18,936,849$1,091,691 â–²6.1%345,6263.4%COM NEWDYNE THERAPEUTICS INC$17,524,621$14,902,987 â–¼-46.0%966,6093.2%COMIVVDInvivyd$14,233,809$4,177,807 â–²41.5%10,949,0842.6%MedicalCADLCandel Therapeutics$14,193,281$14,193,281 â–²New Holding2,896,5882.6%MedicalOCSOculis$13,740,6750.0%516,7612.5%MedicalOVIDOvid Therapeutics$9,249,999$3,699,999 â–²66.7%4,166,6661.7%MedicalINHIBIKASE THERAPEUTICS INC$6,490,588$11,165 â–²0.2%3,863,4451.2%COM NEWZURAZura Bio$4,402,762$4,402,762 â–²New Holding739,9600.8%MedicalALTO NEUROSCIENCE INC$2,000,698$2,000,698 â–²New Holding88,9990.4%COM SHSSATELLOS BIOSCIENCE INC$1,970,500$1,970,500 â–²New Holding350,0000.4%COMOCULOcular Therapeutix$0$18,269,243 â–¼-100.0%00.0%MedicalCNTACentessa Pharmaceuticals$0$7,070,127 â–¼-100.0%00.0%MedicalIVAInventiva$0$1,316,722 â–¼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
